On the stock market since 2019, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
No real growth. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
Executives buying with their own money is usually read as confidence in the company’s future.
The stock trades 34% below its peak. The market has trimmed its expectations for the company.
Over the last 12 months, company executives reported 6 buys and 4 sells. Management buying with its own money is usually read as a good sign.
It pays out $1.05 per share each year — regular cash for whoever holds the stock.
A loss of $12.9M against -$5.1M in annual sales. And on top of that, sales fell from the year before.
At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.
On our five-subject report card, RMM sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: RMM is a high-risk stock — not yet profitable, and its future rides on its product catching on.